Form D — Pulmatrix, Inc.
0001493152-26-016816 · filed Apr 15, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $1,000,000
- Reported amount sold
- $1,000,000
- Minimum investment
- $1,000,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Pulmatrix, Inc.
- CIK
- 1574235
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 945 CONCORD STREET
FRAMINGHAM, Massachusetts 01701 - Phone
- (888) 355-4440
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Michael Higgins · DirectorFRAMINGHAM, Massachusetts Find on LinkedIn ↗
-
Todd Bazemore · DirectorFRAMINGHAM, Massachusetts Find on LinkedIn ↗
-
Richard Batycky · DirectorFRAMINGHAM, Massachusetts Find on LinkedIn ↗
-
Christopher Cabell · DirectorFRAMINGHAM, Massachusetts Find on LinkedIn ↗
-
Anand Varadan · DirectorFRAMINGHAM, Massachusetts Find on LinkedIn ↗
-
Peter Ludlum · Executive OfficerFRAMINGHAM, Massachusetts Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗